ArticleBMC cancer2026
An exploratory ATR-FTIR spectroscopic study of serum protein structural alterations in oral squamous cell carcinoma and oral potentially malignant disorders.
Article in BMC cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIdentification of disease-associated spectral alterations of oral squamous cell carcinoma (OSCC) and oral potentially malignant disorders (OPMD) is critical to improving patient outcomes. Protein structural changes in serum can be investigated using a minimally invasive, potential adjunctive analytical method. This preliminary, exploratory study aimed to explore the ability of attenuated total reflection–Fourier transform infrared (ATR-FTIR) spectroscopy to characterize disease-associated serum protein structural alterations in OSCC and OPMDs relative to healthy controls (HCs).
methodsA laboratory-based analytical study was conducted using 110 serum samples from clinically and histopathologically confirmed cases: OSCC (n = 22), oral leukoplakia (OLK) (n = 22), oral lichen planus (OLP) (n = 22), oral submucous fibrosis (OSF) (n = 22), and HCs (n = 22). Spectral data were obtained with a FTIR over the 400–4000 cm⁻¹ range. Protein secondary structure alterations were analyzed using spectral deconvolution and Gaussian curve fitting. The relevance of specific wavenumbers was evaluated, and sensitivity and specificity were calculated to describe their ability to differentiate diseased groups from HCs in an exploratory manner.
resultsAlterations in the Amide I region were evident in serum samples from OSCC and OLK compared with controls, although no direct statistical comparison between disease groups was performed. Ten wavenumbers (1372, 1381, 1390, 1398, 1412, 1421, 1609, 1635, 1665, and 1683 cm⁻¹) showed statistically significant disease-associated differences between diseased groups and healthy controls. Among the evaluated spectral features, the wavenumber 1390 cm⁻¹ showed the highest sensitivity and specificity values for distinguishing OSCC from HCs (77.3% sensitivity, 86.4% specificity) and OLK from HCs (86.4% sensitivity, 77.3% specificity).
conclusionsATR-FTIR spectroscopy revealed distinct protein structural alterations in serum samples from patients with OSCC and OPMD when compared with healthy individuals. Specific spectral features, particularly at 1381 cm⁻¹ and 1683 cm⁻¹, demonstrated consistent disease-associated alterations compared with HCs, indicating their potential utility as minimally invasive serum-based spectral markers in exploratory studies of oral cancer and OPMD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.